CRABP2 and cancer: Gene Expression Profiling Interactive Analysis 2 (GEPIA2) data showed that compared to normal tissues, the expression level of CRABP2 in various cancers is inconsistent, either upregulated or downregulated, with the highest upregulation observed in ovarian cancer (Fig. S2A and B).